ClinicalTrials.Veeva

Menu

The Biomarker and Cardiac Function in Sepsis

National Taiwan University logo

National Taiwan University

Status

Unknown

Conditions

Sepsis

Study type

Observational

Funder types

Other

Identifiers

NCT00800631
200708002R

Details and patient eligibility

About

The development and severity of sepsis induced myocardial dysfunction can be monitored from the serum biomarker.

Enrollment

150 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Sepsis patients with 2 of the followings when arrival ER and treated > 6 hours:

    • BT >38℃ or<36℃
    • HR >90/min
    • RR >20/min or PaCO2 < 32 mmHg
    • WBC count >12×109/L or <4×109/L or immature form >10%

Exclusion criteria

  • Age < 18
  • Major trauma patients
  • Pregnancy
  • Willing to do not aggressive treatment

Trial contacts and locations

1

Loading...

Central trial contact

ChiungYuan Hsu, Mph

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems